Author: inadim
— last modified 09 July 2009 Expand your business in the pharmaceutical industry through the Entrepreneurship and Innovation Programme developed by the European Commission to support innovation and SMEs in…
— last modified 15 July 2009 The pharmaceutical sector is extensively regulated by the European Union in the dual interest of protecting public health while completing the single market for…
— last modified 05 July 2011 The body of European Union legislation in the pharmaceutical sector is compiled in Volume 1 and Volume 5 of the publication The rules governing…
— last modified 09 July 2009 The European Commission is an active member of the World Health Organisations International Medical Products Task Force (IMPACT). IMPACT counts all the major anti-counterfeiting…
— last modified 09 July 2009 Research and development (R&D) in life sciences is a precondition to pharmaceutical innovation. The Commission recognises the key role pharmaceutical R&D plays. Consequently, it…
— last modified 09 July 2009 The EU Transparency Directive lays down harmonised provisions to ensure the transparency of measures adopted by national authorities to regulate the pricing and reimbursement…
— last modified 24 July 2009 This factsheet focuses on the EU funds available to site managers under the rural development programmes of the CAP.AdvertisementThere are several EU funds available…